Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Other Non-Current Assets of $2.6 million for Q1 2026, down 50.98% year-over-year from $5.4 million in Q1 2025, and down 23.49% quarter-over-quarter from $3.4 million in Q4 2025.
Aurora Cannabis (ACB) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Non-Current Assets for 9 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 50.98% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 50.98% YoY), while the FY2026 annual figure was $2.6 million, down 52.51% from the prior year.
- Other Non-Current Assets retreated to $2.6 million in Q1 2026 per ACB's latest filing, from $3.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.1 million in Q4 2022 and bottomed at $2.0 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $6.7 million across 5 years, with a median of $6.6 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 529.74% — and 2026, when it slumped 50.98%.
- Aurora Cannabis' Other Non-Current Assets stood at $13.1 million in 2022, then retreated by 26.89% to $9.5 million in 2023, then tumbled by 31.32% to $6.6 million in 2024, then slumped by 47.39% to $3.4 million in 2025, then dropped by 23.49% to $2.6 million in 2026.
- Business Quant data shows ACB's Other Non-Current Assets at $2.6 million in Q1 2026, $3.4 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | 7.43 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 8.93 Mn |
| Dec 31, 2023 | 9.54 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 11.87 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 13.05 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 2.88 Mn |